COMMUNIQUÉS West-GlobeNewswire

Syneos Health Introduces FSP 360 – Next Evolution Model Provides Customers Broadest Range of Functional Service Provider Solutions
24/06/2019
Evolved Model Delivers Customized Solutions Across Entire Asset Portfolio MORRISVILLE, N.C., June 24, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions [...]
Pluristem Completes Transition Period of Co-CEO Structure Yaky Yanay appointed as Chief Executive Officer and Zami Aberman appointed as Executive Chairman of the Board
24/06/2019
HAIFA, Israel, June 24, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc . (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced the [...]
Axsome Therapeutics Initiates GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder
24/06/2019
First patient enrolled in placebo-controlled GEMINI study Topline results anticipated in 2H 2019 NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical [...]
Athenex Announces U.S. FDA Allowance of Investigational New Drug Application for PT01 (Pegtomarginase)
24/06/2019
BUFFALO, N.Y., June 24, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Connectivity Wireless Strengthens Leadership Team
24/06/2019
ATLANTA, June 24, 2019 (GLOBE NEWSWIRE) -- Connectivity Wireless Solutions today celebrates the completion of its integration with Neutral Connect Networks. Since the acquisition of Connectivity Wireless was first [...]
MediPharm Labs Receives Permits and Ships First Medical Cannabis Concentrate to Australia
24/06/2019
TORONTO, June 24, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) , a leader in specialized, research-driven cannabis extraction and cannabinoid [...]
Exactus, Inc. Announces Appointment of Bobby Yampolsky to its Board of Directors
24/06/2019
DELRAY BEACH, Fla., June 24, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) (the “Company”), a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, is pleased to announce the [...]
Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
24/06/2019
RANCHO CUCAMONGA, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President, will be presenting at the BMO Prescriptions for Success [...]
Parallax Health Sciences Behavioral Health Division Announces the Development of Compass-ASD Version 2.0, its Data Driven Mobile Application
24/06/2019
SANTA MONICA, CA, June 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, today announced that [...]
Mesoblast Heart Failure Cell Therapy Receives Orphan Drug Designation From FDA for Prevention of Gastrointestinal Bleeding in Patients With Left Ventricular Assist Devices
24/06/2019
NEW YORK and MELBOURNE, Australia, June 24, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq: MESO), global leader in cellular medicines for inflammatory diseases, announced today that the United States Food [...]
R1 Showcases Latest Advancements in Automated Revenue Cycle Management at HFMA 2019 Annual Conference
24/06/2019
Builds largest digital workforce in healthcare revenue cycle with more than four million automated transactions annually to deliver superior financial results CHICAGO, June 24, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc . ( [...]
Affimed Announces Clinical Data Update on Lead Product Candidate AFM13 in CD30+ lymphoma at ICML 2019
24/06/2019
Heidelberg, Germany, June 24, 2019 – Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer, today announced the presentation of [...]
ALK submits registration application for tree SLIT-tablet in Canada
24/06/2019
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) today announced that the Canadian regulatory filing for its investigational tree pollen sublingual allergy immunotherapy (SLIT) tablet has been accepted for review by the [...]
RECORDATI RARE DISEASES, A WORLDWIDE LEADER IN RARE DISEASES AND ORPHAN DRUGS
24/06/2019
RECORDATI RARE DISEASES, A WORLDWIDE LEADER IN RARE DISEASES AND ORPHAN DRUGS Milan, 24 June 2019 – Recordati Rare Diseases, a worldwide leader in rare diseases and orphan drugs, today reported that its strategy aimed [...]
Motif Bio Presents New Iclaprim Data at ASM Microbe 2019
24/06/2019
NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today reported that new iclaprim data were presented [...]
BBS completes final manufacturing steps for CE marking
24/06/2019
BBS – Bioactive Bone Substitutes, an innovator in orthobiologics, today announced that the company’s ARTEBONE ® production line is ready for the audit required for CE marking. Following a successful audit, the certified [...]
ERYTECH Announces Opening of Operations at its New Princeton, NJ GMP Manufacturing Facility
24/06/2019
Inauguration event held last week to officially open 30,000 sq. ft GMP manufacturing facility constructed in Princeton, NJ to produce lead product candidate eryaspase in the United States PRINCETON, N.J. and CAMBRIDGE, [...]
ERYTECH annonce l’ouverture de son nouveau site de production conforme aux BPF à Princeton, dans le New Jersey (États-Unis)
24/06/2019
Inauguration officielle la semaine dernière du site de production conforme aux BPF (Bonnes Pratiques de Fabrication) d’environ 3 000 m 2 construit à Princeton, dans le New Jersey pour produire le candidat médicament, [...]
UK's MHRA renews EAMS Scientific Opinion for Santhera's Idebenone in Duchenne Muscular Dystrophy
24/06/2019
Pratteln, Switzerland, June 24, 2019 - Santhera Pharmaceuticals (SIX: SANN) announces that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has renewed for a further year the Early Access to Medicines [...]

Pages